In vitro Susceptibility of Avian Mycoplasmas to Enrofloxacin, Sarafloxacin, Tylosin, and Oxytetracycline
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
In vitro susceptibility of avian Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline was determined by a serial broth dilution method. The minimum inhibitory concentration (MIC) was recognized by a conversion of the pH indicator phenol red in culture media to a yellow color. Each isolate or type strain of mycoplasma was tested in two replicates. The MICs of tylosin, enrofloxacin, sarafloxacin, and oxytetracycline against five isolates and two reference strains of MG (approximately 10(5) colony-forming units [CFU]/ml) were 0.05, 0.14, 0.37, and 1.30 microg/ml, respectively. The MICs of the four antimicrobial agents against six isolates and one reference strain of MS (approximate 10(5) CFU/ml) were 0.13, 1.82, 1.76, and 0.91 microg/ml, respectively. There were no differences (P > 0.05) between tylosin, enrofloxacin, and sarafloxacin against MG, but these three antibiotics were different (P < 0.05) from oxytetracycline. The MIC value of tylosin against MS was different (P < 0.05) from those of sarafloxacin and enrofloxacin, but it was not different (P > 0.05) from that of oxytetracycline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, complex therapy, including the sequential use of various drugs and combinations of drugs from different pharmacological groups (example protocol: enrofloxacin therapy for 10-14 days followed by replacement with tylosin), has increasingly demonstrated the best results in practice [64].”
From Mycoplasma Contamination of Primary Cell Cultures (2026) · cites this paper as [64]
Citations
Cites
A medium for the isolation of avian mycoplasmas.
Frey, M. L., Hanson, R. P., & Andrson, D. P. (1968) · PubMed · Cited by 479
Economic Impact of Mycoplasma gallisepticum and M. synoviae in Commercial Layer Flocks
Mohammed, H. O., Carpenter, T. E., & YAMAMOTO, R. S. (1987) · Avian Diseases · doi:10.2307/1590727 · Cited by 155
HANNAN, P. C. T., O’Hanlon, P. J., & ROGERS, N. H. (1989) · Research in Veterinary Science · doi:10.1016/s0034-5288(18)31146-9 · Cited by 104
Whithear, K. G., Bowtell, D. D. L., Ghiocas, E., & Hughes, K. L. (1983) · Avian Diseases · doi:10.2307/1590195 · Cited by 72
Jordan, F. T. W., & Horrocks, B. K. (1996) · Avian Diseases · doi:10.2307/1592228 · Cited by 66
Bradbury, J. M., Yavari, C. A., & Giles, C. (1994) · Avian Pathology · doi:10.1080/03079459408418978 · Cited by 55
Effects of Baytril, Tylosin and Iamulin on avian mycoplasmas
Jordan, F. T. W., Gilbert, S., Knight, D. L., & Yavari, C. A. (1989) · Avian Pathology · doi:10.1080/03079458908418640 · Cited by 51
Jordan, F. T. W., Forrester, C. A., Ripley, P. H., & Burch, D. G. S. (1998) · Avian Diseases · doi:10.2307/1592709 · Cited by 51
Tanner, A. C., & Wu, C.-C. (1992) · Avian Diseases · doi:10.2307/1591770 · Cited by 48
Ley, D. H., Avakian, A. P., & Berkhoff, J. E. (1993) · Avian Diseases · doi:10.2307/1592041 · Cited by 47
Cited by
Antimicrobial Resistance in Mycoplasma spp
Gautier-Bouchardon, A. V. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0030-2018 · Cited by 207
“Several studies report in vitro susceptibility levels of M. synoviae fi eld isolates (29, 32, 41, 47, 74 – 76, 81, 82) (Table 3).”
BackgroundControl of Avian Mycoplasma Infections in Commercial Poultry
Kleven, S. H. (2008) · Avian Diseases · doi:10.1637/8323-041808-review.1 · Cited by 211
“There are also numerous reports of efficacy testing of various antibiotics in infection models (23,52,57,67,68,106,130,135) and in naturally infected birds (126).”
BackgroundPakpinyo, S., & Sasipreeyajan, J. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.05.011 · Cited by 62
Epidemiological study on Mycoplasma synoviae infection in layers
Dufour-Gesbert, F., Dheilly, A., Marois‐Créhan, C., & Kempf, I. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.10.040 · Cited by 54
Kreizinger, Z., Grózner, D., Sulyok, K. M., Nilsson, K., Hrivnák, V., Benčina, D., & Gyuranecz, M. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1266-2 · Cited by 51
Pergola, S., Franciosini, M. P., Comitini, F., Ciani, M., Luca, S. D., Bellucci, S., Menchetti, L., & Proietti, P. C. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13419 · Cited by 49
“Indeed, macrolides are largely used in the therapy of mycoplasmosis (Bradbury et al. 1994; Jordan et al. 1998; Wang et al. 2001) and clostridiosis (Brennan et al. 2001; Collier et al. 2003), since they have short or no withdrawal time.”
BackgroundMolecular Characterization of Acquired Enrofloxacin Resistance in Mycoplasma synoviae Field Isolates
Lysnyansky, I., Gerchman, I., Mikula, I., Gobbo, F., Catania, S., & Levisohn, S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00203-13 · Cited by 41
Catania, S., Bottinelli, M., Fincato, A., Gastaldelli, M., Barberio, A., Gobbo, F., & Vicenzoni, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224903 · Cited by 38
“several authors have been reporting decreased susceptibility to fluoroquinolones worldwide [20,21,23,24] and elucidations on molecular acquired resistance to enrofloxacin in MS were proposed [13,15].”
BackgroundDemir, Ö., Balkan, D., Peker, R. C., Metin, M., & Arıkoğlu, A. (2018) · Journal of Sandwich Structures & Materials · doi:10.1177/1099636218767491 · Cited by 35
Carrou, J. L., Reinhardt, A. K., Kempf, I., & Gautier‐Bouchardon, A. V. (2005) · Veterinary Research · doi:10.1051/vetres:2005046 · Cited by 33
“synoviae isolates displaying increased enrofloxacin MIC have been isolated [37] and development of resistant M.”
BackgroundSimjee, S., McDermott, P. F., White, D. G., Hofacre, C. L., Berghaus, R. D., Carter, P. J., Stewart, L., Liu, T., Maier, M., & Maurer, J. J. (2007) · Avian Diseases · doi:10.1637/7973-032607-regr.1 · Cited by 32
“The administration of antimicrobials is often dictated by cost, regulations governing antimicrobial residues in processed foods, and the general susceptibility of veterinary pathogens (7,23,26, 58,59).”
BackgroundAntibiotic susceptibility profiles of Mycoplasma sp. 1220 strains isolated from geese in Hungary
Grózner, D., Kreizinger, Z., Sulyok, K. M., Rónai, Z., Hrivnák, V., Turcsányi, I., Jánosi, S., & Gyuranecz, M. (2016) · BMC Veterinary Research · doi:10.1186/s12917-016-0799-0 · Cited by 27
“Mycoplasma infected waterfowl and poultry flocks are usually treated with macrolides, pleuromutilins or with the combination of lincomycin and spectinomycin [3, 11–18].”
BackgroundResultJi, L. ‐., Li, D., Ji, H., Feng, X. ‐., Li, D., Ding, R. ‐., & Jiang, S. (2013) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12092 · Cited by 27
“…1975; MIC = 0.05 lg/mL: Wang et al., 2001) Mycoplasma meleagridis (MIC = 0.1 lg/mL: Wise & Fuller, 1975), Mycoplasma synoviae (MIC = 0.13 lg/mL: Wang et al., 2001), Mycoplasma agalactiae (MIC50 = 0.292 lg/mL: Loria et al., 2003), and field isolates of mycoplasma from poultry (MIC = 0.08~2…”
BackgroundInfluentialAllometric analysis of tylosin tartrate pharmacokinetics in growing male turkeys
Poźniak, B., Tikhomirov, M., Motykiewicz‐Pers, K., Bobrek, K., & Świtała, M. (2020) · Journal of Veterinary Science · doi:10.4142/jvs.2020.21.e35 · Cited by 22
“05 μg/mL—the minimum inhibitory concentration for Mycoplasma gallisepticum [29]—was maintained for 4.”
BackgroundLandman, W. J. M., Mevius, D. J., Veldman, K. T., & Feberwee, A. (2008) · Avian Pathology · doi:10.1080/03079450802216637 · Cited by 22
“synoviae strains have been published (Jordan and Knight, 1984; Bradbury et al., 1994; Jordan and Horrocks, 1996; Wang et al., 2001; Cerda et al., 2002).”
Eradication of Mycoplasma synoviae from a multi-age broiler breeder farm using antibiotics therapy
Hong, Y.-H., Kwon, J.-S., Lee, H. J., Song, C., & Lee, S. (2015) · Poultry Science · doi:10.3382/ps/pev232 · Cited by 18
“Previous reports have suggested that the antibiotics susceptibilities of avian mycoplasmas may be different between species and strains (Jordan and Horrocks, 1996; Stanley et al., 2001; Wang et al., 2001).”
ResultBottinelli, M., Gastaldelli, M., Picchi, M., Dall’Ora, A., Borges, L. C., Ramírez, A. S., Matucci, A., & Catania, S. (2022) · Antibiotics · doi:10.3390/antibiotics11081021 · Cited by 17
Limpavithayakul, K., Sasipreeyajan, J., & Pakpinyo, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-29266-9 · Cited by 12
Antimicrobial minimum inhibitory concentration of Mycoplasma gallisepticum: a systematic review
Taiyari, H., Faiz, N. M., Abu, J., & Zakaria, Z. (2021) · The Journal of Applied Poultry Research · doi:10.1016/j.japr.2021.100160 · Cited by 11
Control of experimental colisepticaemia in broiler chickens using sarafloxacin.
El‐Ghany, W. A. A., & Madian, K. (2011) · Life science journal · Cited by 10
Antimicrobial Resistance in Mycoplasma spp.
Gautier‐Bouchardon, A. V. (2018) · ASM Press eBooks · doi:10.1128/9781555819804.ch20 · Cited by 13
Swayne, D. E. (2013) · Wiley eBooks · doi:10.1002/9781119421481.ch21 · Cited by 6
Aarestrup, F. M., & Kempf, I. (2019) · ASM Press eBooks · doi:10.1128/9781555817534.ch14 · Cited by 5
(AHAW), E. P. O. A. H. A. W., More, S. J., Bøtner, A. G., Butterworth, A., Calistri, P., Depner, K., Edwards, S. A., Garin‐Bastuji, B., Good, M., Schmidt, C. G., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4953 · Cited by 5
Liao, C., Chen, Y., Yan, Z., Song, Y., Zhou, Q., Zhu, P., XuDong, H., Li, W., & Chen, F. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1354548 · Cited by 4
Kibeida, O. A. I. (2011) · UpSpace Institutional Repository (University of Pretoria) · Cited by 4
Mycoplasma Contamination of Primary Cell Cultures
A. Leonovich, O. (2026) · Biochemistry · doi:10.5772/intechopen.1013412 · Cited by 1
Current Knowledge of Avian Mycoplasmosis
Wanasawaeng, W., Nimitkun, C., & Chansiripornchai, N. (2006) · Cited by 1
Antibacterial susceptibility testing of Mycoplasma gallisepticum isolated from poultry
AHER, T. S., Gandge, R. S., & Bhave, S. S. (2019) · The Indian Journal of Animal Sciences · doi:10.56093/ijans.v89i11.95864 · Cited by 1
“The MIC of oxytetracycline and enrofloxacin observed in present study was similar to MICs reported by Bradbury (2007) and Wang et al. (2001).”
ResultSiddique, A. B., Rahman, S. U., Ulhaq, M., & Naveed, R. (2020) · Slovenian Veterinary Research · doi:10.26873/svr-598-2020 · Cited by 1
“The isolates were subjected to a broth microdilution technique to determine the Minimum Inhibitory Concentrations (MICs) as described previously (12, 24, 25).”
BackgroundMethodavian mycoplasmosis (Mycoplasma synoviae)
Behboudi, S. (2022) · CABI Compendium · doi:10.1079/cabicompendium.74552 · Cited by 1
Collett, S. R. (2007) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Matham, V., Reddy, A. G., Nadoor, P., & Reddy, M. R. (2020) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2020.908.238
Immune Targets Druggability of Mycoplasma synoviae in Chicken
Matham, V., Reddy, A. G., Prakash, N., & Reddy, M. R. (2022) · Indian Journal of Animal Research · doi:10.18805/ijar.b-4863
Metadata
- Authors
- Wang, C., Ewing, M., & A'arabi, S. Y.
- Affiliations
- Mississippi State University (US)
- ORCID
- Wang, C.
- Venue
- Avian Diseases
- Publisher
- JSTOR
- Published
- 2001-04
- Volume
- 45
- Issue
- 2
- Pages
- 456
- ISSN
- 0005-2086 (ISSN-L)
- OpenAlex
- W2007440950
- Cited by
- 34
- References
- 14
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 1 · 2013: 3
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Avian Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- avian mycoplasma, Mycoplasma gallisepticum, Mycoplasma synoviae, enrofloxacin, sarafloxacin, tylosin, oxytetracycline, antimicrobial susceptibility, minimum inhibitory concentration, poultry
- MeSH terms
- Enrofloxacin, Animals, Anti-Infective Agents, Anti-Bacterial Agents, Cells, Cultured, Ciprofloxacin, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Mycoplasma, Oxytetracycline, Quinolones, Tylosin, Fluoroquinolones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.